J CADY
Overview
Explore the profile of J CADY including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
67
Citations
76
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
2.
3.
4.
CADY J
Oncol Nurs Forum
. 2002 Jan;
28(10):1561-8; quiz 1569-70.
PMID: 11759304
Purpose/objectives: To review opioid tolerance in chronic cancer pain, define the phenomenon and its scope, review physiologic mechanisms, and discuss clinical strategies to identify and manage this complex issue. Data...
5.
Tournigand C, Louvet C, Molitor J, Dehni N, Lejeune V, Sezeur A, et al.
Gynecol Oncol
. 2001 Oct;
83(2):198-204.
PMID: 11606072
Objective: The efficacy of a cisplatin-anthracycline combination, early debulking surgery, and intraperitoneal chemotherapy has been demonstrated through separate studies. We evaluated a multimodal treatment strategy integrating these therapeutic options. Methods:...
6.
Kron B, Kron C, CADY J
Chirurgie
. 1998 Sep;
123(3):292-5; discussion 296.
PMID: 9752521
Study Aim: The aim of this study is to demonstrate the reliability of silicone prosthesis for the replacement of ureters. This prosthesis derives from the biliary prosthesis developed after a...
7.
Choyke P, CADY J, DePollar S, Austin H
Tech Urol
. 1998 Jun;
4(2):65-9.
PMID: 9623618
The risk of contrast-associated nephrotoxicity (CAN) is increased in the presence of preexisting renal disease. Although routine determination of serum creatinine (Cr) prior to imaging studies is the traditional method...
8.
Long-term follow-up after adjuvant chemotherapy in completely resected early stage ovarian carcinoma
Raymond E, Drolet Y, Marpeau L, Louvet C, CADY J, Tessier C, et al.
Eur J Obstet Gynecol Reprod Biol
. 1997 Apr;
72(2):181-90.
PMID: 9134399
Objective: To evaluate the impact of standardized staging, surgery and adjuvant chemotherapy on survival of patients with completely resected early ovarian carcinoma. Study Design: We performed a multicentric retrospective analysis...
9.
Tournigand C, Louvet C, de Gramont A, Lucchi E, Seitz J, Mal F, et al.
Cancer
. 1997 Mar;
79(6):1094-9.
PMID: 9070485
Unlabelled: BACKGROUND; The rationale for the modulation of 5-fluorouracil (5-FU) with interferon-alpha (IFN) is inhibition of 5-FU catabolism and 5-FU resistance. Clinical trials have shown debatable results when IFN is...
10.
de Gramont A, Pigne A, Louvet C, Sezeur A, Marpeau L, Vaillant J, et al.
Ann Chir
. 1997 Jan;
51(10):1069-76.
PMID: 10868028
The main prognostic factor in advanced ovarian cancer is the volume of residual disease after the initial laparotomy. Early debulking surgery after several cycles of chemotherapy, before the emergence of...